Caris Life Sciences (CAI) Other Working Capital Changes (2024 - 2026)

Caris Life Sciences' Other Working Capital Changes history runs 3 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 162.91% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $9.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $5.1 million, up 265.77% from the prior year.
• Other Working Capital Changes rose to $1.6 million in Q1 2026 per CAI's latest filing, from $345000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $4.7 million in Q2 2025 and bottomed at -$2.5 million in Q1 2025.
• The 3-year median for Other Working Capital Changes is $793000.0 (2024), against an average of $961285.7.
• Biggest YoY gain for Other Working Capital Changes was 220.3% in 2025; the steepest drop was 144.92% in 2025.
• Year by year, Other Working Capital Changes stood at -$768000.0 in 2024, then jumped by 144.92% to $345000.0 in 2025, then soared by 350.43% to $1.6 million in 2026.
• Per Business Quant, the three latest CAI Other Working Capital Changes figures stand at $1.6 million (Q1 2026), $345000.0 (Q4 2025), and $2.5 million (Q3 2025).